These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Inhibitive effect of bcl-2 antisense oligodeoxynucleotide on Bcl-2 protein synthesis and cell proliferation in human laryngocarcinoma Hep-2 cells].
    Author: Jing H, Huang W, Qiu J.
    Journal: Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Feb; 33(1):17-20. PubMed ID: 11498881.
    Abstract:
    OBJECTIVES: To evaluate the role of bcl-2 antisense oligodeoxynucleotide in the gene treatment of human laryngocarcinoma. METHODS: An antisense oligodeoxynucleotide complementary to the initiation coden and the next four codens of bcl-2 mRNA was synthesized with an automatic DNA synthesizer. It was used to treat cultured Hep-2 cells to observe its effect on cell proliferation. In situ hybridization method and immunohistochemical technology were adopted to detect bcl-2 mRNA and protein and explore the effect of bcl-2 antisense oligodeoxynucleotide fragment on bcl-2 gene expression and protein synthesis and inhibition of cell proliferation. RESULTS: Bcl-2 antisense oligodeoxynucleotide had an obvious effect on bcl-2 mRNA, but inhibited Bcl-2 protein synthesis significantly, the inhibitive rate had positive correlation with concentration of antisense oligodeoxynucleotide and time of action. Twenty mumol/L of antisense oligodeoxynucleotide could inhibit cell proliferation effectively. CONCLUSIONS: It is suggested that bcl-2 antisense oligodeoxynucleotide might specifically inhibit bcl-2 protein synthesis and cell proliferation in Hep-2 cells at translation level.
    [Abstract] [Full Text] [Related] [New Search]